The emergence of dual agonists like Tirzepatide shows how combining pathways can significantly enhance outcomes, raising the bar for both efficacy and patient results
Nausea: the most common challenge Nausea is the hallmark side effect of all GLP-1 and GIP receptor agonists
Antioxid Redox Signal 38:599618 Che X, Brydges CR, Yu Y, Price A, Joshi S, Roy A, Lee B, Barupal DK, Cheng A, Palmer DM, Levine S, Peterson DL, Vernon SD, Bateman L, Hornig M, Montoya JG, Komaroff AL, Fiehn O, Lipkin WI (2022) Evidence for peroxisomal dysfunction and dysregulation of the CDP-choline pathway in myalgic encephalomyelitis/chronic fatigue syndrome
Sundaram, K., Murugaian, J
Whos a Good Candidate for Glutathione Injections